Previous 10 | Next 10 |
Encision press release ( OTCPK:ECIA ): FQ1 GAAP EPS of $0.02. Revenue of $2.15M (+7.0% Y/Y). Gross margin on net revenue was 60% in the fiscal 2023 first quarter and 51% in the fiscal 2022 first quarter. For further details see: Encision GAAP EPS of $0.02, revenu...
BOULDER, CO / ACCESSWIRE / August 9, 2022 / Encision Inc. (OTC PINK:ECIA), a medical device company owning patented Active Electrode Monitoring (AEM®) Technology that prevents dangerous radiant energy burns in minimally invasive surgery, today announced financial results for its fiscal ...
Encision press release (OTCPK:ECIA): Q4 GAAP EPS of -$0.03. Revenue of $1.6M (-25.6% Y/Y). Gross margin on net revenue was 50% in the fiscal 2022 fourth quarter and 54% in the fiscal 2021 fourth quarter. For further details see: Encision GAAP EPS of -$0.03, revenue of $1.6M
BOULDER, CO / ACCESSWIRE / June 16, 2022 / Encision Inc. (OTCPK:ECIA), a medical device company owning patented Active Electrode Monitoring (AEM®) Technology that prevents dangerous radiant energy burns in minimally invasive surgery, today announced financial results for its fiscal 2022...
Encision press release (OTCPK:ECIA): FQ3 GAAP EPS of $0.00. Revenue of $1.94M (-10.2% Y/Y). Gross margin on net revenue was 52% in the fiscal 2022 third quarter and 51% in the fiscal 2021 third quarter. For further details see: Encision GAAP EPS of $0.00, revenue of $1.94M
BOULDER, CO / ACCESSWIRE / February 10, 2022 / Encision Inc. (OTC PINK:ECIA), a medical device company owning patented Active Electrode Monitoring (AEM®) Technology that prevents dangerous radiant energy burns in minimally invasive surgery, today announced financial results for its fisc...
Encision (OTCPK:ECIA): FQ2 GAAP EPS of $0.03. Revenue of $2.11M (+12.2% Y/Y) Press Release For further details see: Encision reports FQ2 results
Encision Reports Second Quarter Fiscal Year 2022 Results PR Newswire BOULDER, Colo. , Nov. 10, 2021 /PRNewswire/ -- Encision Inc. (PK:ECIA), a medical device company owning patented Active Electrode Monitoring (AEM®) Technology that prevents dangerous r...
Encision Signs Supply Agreement with Auris Health, Inc. PR Newswire BOULDER, Colo. , Aug. 24, 2021 /PRNewswire/ -- Encision Inc. (PK:ECIA), a medical device company owning patented Active Electrode Monitoring (AEM®) Technology that prevents dangerous st...
Encision Reports First Quarter Fiscal Year 2022 Results PR Newswire BOULDER, Colo. , Aug. 9, 2021 /PRNewswire/ -- Encision Inc. (PK:ECIA), a medical device company owning patented Active Electrode Monitoring (AEM®) Technology that prevents dangerous str...
News, Short Squeeze, Breakout and More Instantly...
BOULDER, CO / ACCESSWIRE / February 14, 2024 / Encision Inc. (OTC PINK:ECIA), a medical device company owning patented Active Electrode Monitoring (AEM®) Technology that prevents dangerous radiant energy burns in minimally invasive surgery, today announced financial results for its fiscal 2...
ESSA Pharma Inc. (EPIX) is expected to report $-0.17 for Q1 2024 QuidelOrtho Corp Com (QDEL) is expected to report $2.01 for Q4 2023 FaZe Holdings Inc. (FAZE) is expected to report for Q4 2023 Portsmouth Square, Inc. (PRSI) is expected to report for Q2 2024 Similarweb Ltd. (SMWB) ...
Algoma Steel Group Inc. (ASTL) is expected to report for Q3 2024 CTS Corporation (CTS) is expected to report for Q4 2023 Xylem Inc. New (XYL) is expected to report $0.96 for Q4 2023 TIM S.A. American Depositary Shares (Each representing 5) (TIMB) is expected to report for Q4 2023 ...